Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Infectious Disease
•
Tuberculosis
•
Pulmonology
•
Pulmonary Infections
•
HIV & AIDS
Do you rule out TB in patients with AIDS and lobar pneumonia?
What’s your threshold to get the three AFBs and place the patient in airborne isolation?
Answer from: at Community Practice
Depends: +Ve Risk Factors: Travel/contact Hx, recent Quantiferon Conversion, changing CXR, Night sweats Unexplained low-grade temps Then, yes. Otherwise, no.
Sign in or Register to read more
17976
Related Questions
Are there clinical scenarios in which you would start empiric treatment for pulmonary TB without microbiologic confirmation?
What is the interpretation of an IGRA with positive TB wells and negative nil and negative mitogen wells?
What is the interpretation of two IGRAs with negative mitogen wells, in the absence of immunosuppression?
How would you approach treatment of latent TB for patients who cannot tolerate rifamycins or isoniazid due to allergy, intolerance, or drug-drug interactions?
Does your institution have formal policies or work flows to reduce unnecessary IGRAs ordered for patients on biologics?
How do you manage resistant infections that persist after stopping antibiotic therapy in patients with non-CF bronchiectasis?
Do you administer prophylactic antibiotics to prevent VAP following intubation in patients with acute brain injury?
Is there any utility to trending Histoplasma serology titers to guide duration of therapy or treatment response for pulmonary histoplasmosis with negative urine antigen?
What are your top takeaways from ID Week 2024?
What is your approach to duration of antibiotic therapy for treatment of a bacterial lung abscess?